help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, I. S.
Right arrow Articles by Choi, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, I. S.
Right arrow Articles by Choi, J. H.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 2069-2075, Copyright © 1996 by Endocrine Society

ARTICLES

Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells

IS Han and JH Choi
College of Pharmacy, University of Michigan, Ann Arbor 48109-1065, USA.

When human breast cancer T47D cells were treated with all-trans- retinoic acid (RA), the RA 4- and 18-hydroxylase activities were induced in microsomes in a time-dependent manner, indicating that these cells readily metabolized RA into more polar compounds, such as all- trans-4-hydroxy-RA and all-trans-18-hydroxy-RA. In contrast, T47D cells treated for 12 h with xenobiotics, such as phenobarbital, beta- naphthoflavone, 3-methylcholanthrene, and dimethylsulfoxide, showed lower levels of catalytic activities for 4- and 18-hydroxylases. The induction of 4- and 18-hydroxylase activities appears to be regulated at the level of transcriptional control (basal level). Competitive assays demonstrated that inhibitors and substrates for 1A, 2A, 3A, 2B, and 2C cytochrome P450 (P450 subfamilies), all-trans-retinol, and all- trans-retinal showed no inhibition of RA metabolism, but other retinoic acid derivatives competed highly with RA. The RA-inducible 4- and 18- hydroxylases showed high specificity for RA and high levels of catalytic activities, with Km and maximum velocity values for 4- hydroxylase equal to 99 nmol/L and 0.26 pmol/min.mg protein, respectively, and those for 18-hydroxylase equal to 65 nmol/L and 0.18 pmol/min.mg protein. Cell-free metabolism of RA required microsomes from RA-treated cells and NADPH, and was inhibited by liarozole, an inhibitor of P450. These data suggest that RA-inducible 4- and 18- hydroxylases may be novel P450 isozymes.


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
G. S. Gorman, L. Coward, C. Kerstner-Wood, L. Cork, I. M. Kapetanovic, W. J. Brouillette, and D. D. Muccio
In Vitro Metabolic Characterization, Phenotyping, and Kinetic Studies of 9cUAB30, a Retinoid X Receptor-Specific Retinoid
Drug Metab. Dispos., July 1, 2007; 35(7): 1157 - 1164.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. V. Chithalen, L. Luu, M. Petkovich, and G. Jones
HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A
J. Lipid Res., July 1, 2002; 43(7): 1133 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E. C. Tibaduiza, J. C. Fleet, R. M. Russell, and N. I. Krinsky
Excentric Cleavage Products of {beta}-Carotene Inhibit Estrogen Receptor Positive and Negative Breast Tumor Cell Growth In Vitro and Inhibit Activator Protein-1-Mediated Transcriptional Activation
J. Nutr., June 1, 2002; 132(6): 1368 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
Q.-Y. Zhang, D. Dunbar, and L. Kaminsky
Human Cytochrome P-450 Metabolism of Retinals to Retinoic Acids
Drug Metab. Dispos., March 1, 2000; 28(3): 292 - 297.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. S. Abu-Abed, B. R. Beckett, H. Chiba, J. V. Chithalen, G. Jones, D. Metzger, P. Chambon, and M. Petkovich
Mouse P450RAI (CYP26) Expression and Retinoic Acid-inducible Retinoic Acid Metabolism in F9 Cells Are Regulated by Retinoic Acid Receptor gamma  and Retinoid X Receptor alpha
J. Biol. Chem., January 23, 1998; 273(4): 2409 - 2415.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. White, B. Beckett-Jones, Y.-D. Guo, F. J. Dilworth, J. Bonasoro, G. Jones, and M. Petkovich
cDNA Cloning of Human Retinoic Acid-metabolizing Enzyme (hP450RAI) Identifies a Novel Family of Cytochromes P450 (CYP26)
J. Biol. Chem., July 25, 1997; 272(30): 18538 - 18541.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B.-j. M. van der Leede, C. E. van den Brink, W. W. M. Pijnappel, E. Sonneveld, P. T. van der Saag, and B. van der Burg
Autoinduction of Retinoic Acid Metabolism to Polar Derivatives with Decreased Biological Activity in Retinoic Acid-sensitive, but Not in Retinoic Acid-resistant Human Breast Cancer Cells
J. Biol. Chem., July 18, 1997; 272(29): 17921 - 17928.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. C. Gaemers, A. M. M. van Pelt, P. T. van der Saag, J. W. Hoogerbrugge, A. P. N. Themmen, and D. G. de Rooij
Effect of Retinoid Status on the Messenger Ribonucleic Acid Expression of Nuclear Retinoid Receptors {alpha}, {beta}, and {gamma}, and Retinoid X Receptors {alpha}, {beta}, and {gamma} in the Mouse Testis
Endocrinology, April 1, 1997; 138(4): 1544 - 1551.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society